Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 2, 2012, Pages

  Verbakel, Wilko F A R ^a   Van Reij, Ellen ^a   Ladenius Lischer, Ilonka ^a   Cuijpers, Johan P ^a   Slotman, Ben J ^a   Senan, Suresh ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

IMRT; RapidArc; Stage III lung cancer; Treatment planning comparison

Indexed keywords

3-DIMENSIONAL; ANTERIOR POSTERIORS; CLINICAL APPLICATION; HOT SPOT; IMRT; INTENSITY-MODULATED RADIATION THERAPY; INTENSITY-MODULATED RADIOTHERAPY; LOW DOSE IRRADIATION; LUNG TUMOR; PLANNING TARGET VOLUMES; RAPIDARC; STAGE III LUNG CANCER; TARGET COVERAGE; THERAPY DELIVERY; TREATMENT PLANNING;

BIOLOGICAL ORGANS; BIOLOGICAL RADIATION EFFECTS; DISEASES; RADIOTHERAPY; TUMORS;

PHYSICAL THERAPY;

ANTERIOR POSTERIOR AXIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; ESOPHAGITIS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION HAZARD; RADIATION PNEUMONIA; TREATMENT OUTCOME; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; ESOPHAGITIS; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 84861017114     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.12.059     Document Type: Article

References (19)

1. A. Aupérin, C. Le Péchoux, and E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
2. K.S. Albain, R.S. Swann, and V.W. Rusch Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: A phase III randomised controlled trial Lancet 374 2009 379 386
3. R. Komaki, R.S. Swann, and D.S. Ettinger Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12 Int J Radiat Oncol Biol Phys 62 2005 342 350 (Pubitemid 40704448)
4. J. Rose, G. Rodrigues, and B. Yaremko Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy Radiother Oncol 91 2009 282 287
5. E.C. Phernambucq, F.O. Spoelstra, and W.F. Verbakel Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity Ann Oncol 22 2011 132 138
6. D. De Ruysscher, C. Faivre-Finn, and U. Nestle European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy of lung cancer J Clin Oncol 28 2010 5301 5310
7. Z.X. Liao, R.R. Komaki, and H.D. Thames Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy Int J Radiat Oncol Biol Phys 76 2010 775 781
8. C.H. Song, H. Pyo, and S.H. Moon Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy Int J Radiat Oncol Biol Phys 78 2010 651 658
9. S. Wang, Z. Liao, and X. Wei Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT) Int J Radiat Oncol Biol Phys 66 2006 1399 1407
10. L. Court, M. Wagar, and R. Berbeco Evaluation of the interplay effect when using RapidArc to treat targets moving in the craniocaudal or right-left direction Med Phys 37 2010 4 11
11. C.S. Mayo, M.M. Urie, and T.J. Fitzgerald Hybrid IMRT for treatment of cancers of the lung and esophagus Int J Radiat Oncol Biol Phys 71 2008 1408 1418
12. R.W. Underberg, J.R. van Sörnsen de Koste, and F.J. Lagerwaard A dosimetric analysis of respiration-gated radiotherapy in patients with Stage III lung cancer Radiat Oncol 1 2006 8
13. C.L. Ong, W.F. Verbakel, and J.P. Cuijpers Stereotactic radiotherapy for peripheral lung tumors: A comparison of volumetric modulated arc therapy with 3 other delivery techniques Radiother Oncol 97 2010 437 442
14. I.S. Vogelius, D.C. Westerly, and G.M. Cannon Intensity-modulated radiotherapy might increase penumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: A modelling study of dose dumping Int J Radiat Oncol Biol Phys 80 2011 893 899
15. A.M. Allen, M. Czerminska, and P.A. Jänne Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma Int J Radiat Oncol Biol Phys 65 2006 640 645 (Pubitemid 43795851)
16. M.V. Graham, J.A. Purdy, and B. Emami Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 1999 323 329 (Pubitemid 29408545)
17. C. Ong, W.F. Verbakel, and J.P. Cuijpers Dosimetric impact of interplay effect on RapidArc lung stereotactic treatment delivery Int J Radiat Oncol Biol Phys 79 2011 305 311
18. M.L. Dirkx, M. Essers, and J.R. van Sornsen de Koste Beam intensity modulation for penumbra enhancement in the treatment of lung cancer Int J Radiat Oncol Biol Phys 44 1999 449 454 (Pubitemid 29205045)
19. H.H. Liu, M. Jauregui, and X. Zhang Beam angle optimization and reduction for intensity-modulated radiation therapy of non-small-cell lung cancers Int J Radiat Oncol Biol Phys 65 2006 561 572